Nicholas A. Feasey
University of Malawi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Nicholas A. Feasey.
Emerging Infectious Diseases | 2015
Trong Ao; Nicholas A. Feasey; Melita A. Gordon; Karen H. Keddy; Frederick J. Angulo; John A. Crump
This disease is associated with approximately 3.4 million illnesses and 681,316 deaths, particularly in Africa.
Emerging Infectious Diseases | 2010
Nicholas A. Feasey; Brett N. Archer; Robert S. Heyderman; Arvinda Sooka; Brigitte Dennis; Melita A. Gordon; Karen H. Keddy
To determine the prevalence of invasive nontyphoid salmonellosis and typhoid fever in Malawi and South Africa, we compared case frequency and patient age distribution. Invasive nontyphoid salmonellosis showed a clear bimodal age distribution; the infection developed in women at a younger age than in men. Case frequency for typhoid fever was lower than for salmonellosis.
PLOS Neglected Tropical Diseases | 2015
Nicholas A. Feasey; Katherine M. Gaskell; Vanessa K. Wong; Chisomo L. Msefula; George Selemani; Save Kumwenda; Theresa J. Allain; Jane Mallewa; Neil Kennedy; Aisleen Bennett; Joram O. Nyirongo; Patience A. Nyondo; Madalitso D. Zulu; Julian Parkhill; Gordon Dougan; Melita A. Gordon; Robert S. Heyderman
Introduction Between 1998 and 2010, S. Typhi was an uncommon cause of bloodstream infection (BSI) in Blantyre, Malawi and it was usually susceptible to first-line antimicrobial therapy. In 2011 an increase in a multidrug resistant (MDR) strain was detected through routine bacteriological surveillance conducted at Queen Elizabeth Central Hospital (QECH). Methods Longitudinal trends in culture-confirmed Typhoid admissions at QECH were described between 1998–2014. A retrospective review of patient cases notes was conducted, focusing on clinical presentation, prevalence of HIV and case-fatality. Isolates of S. Typhi were sequenced and the phylogeny of Typhoid in Blantyre was reconstructed and placed in a global context. Results Between 1998–2010, there were a mean of 14 microbiological diagnoses of Typhoid/year at QECH, of which 6.8% were MDR. This increased to 67 in 2011 and 782 in 2014 at which time 97% were MDR. The disease predominantly affected children and young adults (median age 11 [IQR 6-21] in 2014). The prevalence of HIV in adult patients was 16.7% [8/48], similar to that of the general population (17.8%). Overall, the case fatality rate was 2.5% (3/94). Complications included anaemia, myocarditis, pneumonia and intestinal perforation. 112 isolates were sequenced and the phylogeny demonstrated the introduction and clonal expansion of the H58 lineage of S. Typhi. Conclusions Since 2011, there has been a rapid increase in the incidence of multidrug resistant, H58-lineage Typhoid in Blantyre. This is one of a number of reports of the re-emergence of Typhoid in Southern and Eastern Africa. There is an urgent need to understand the reservoirs and transmission of disease and how to arrest this regional increase.
Nature Genetics | 2016
Nicholas A. Feasey; James Hadfield; Karen H. Keddy; Timothy J. Dallman; Jan Jacobs; Xiangyu Deng; Paul Wigley; Lars Barquist; Gemma C. Langridge; Theresa Feltwell; Simon R. Harris; Alison E. Mather; Maria Fookes; Martin Aslett; Chisomo L. Msefula; Samuel Kariuki; Calman A. MacLennan; Robert S. Onsare; F X Weill; Simon Le Hello; Anthony M. Smith; Michael McClelland; Prerak T. Desai; Christopher M. Parry; John S. Cheesbrough; Neil French; Josefina Campos; José A. Chabalgoity; Laura Betancor; Katie L. Hopkins
An epidemiological paradox surrounds Salmonella enterica serovar Enteritidis. In high-income settings, it has been responsible for an epidemic of poultry-associated, self-limiting enterocolitis, whereas in sub-Saharan Africa it is a major cause of invasive nontyphoidal Salmonella disease, associated with high case fatality. By whole-genome sequence analysis of 675 isolates of S. Enteritidis from 45 countries, we show the existence of a global epidemic clade and two new clades of S. Enteritidis that are geographically restricted to distinct regions of Africa. The African isolates display genomic degradation, a novel prophage repertoire, and an expanded multidrug resistance plasmid. S. Enteritidis is a further example of a Salmonella serotype that displays niche plasticity, with distinct clades that enable it to become a prominent cause of gastroenteritis in association with the industrial production of eggs and of multidrug-resistant, bloodstream-invasive infection in Africa.
PLOS ONE | 2014
Nicholas A. Feasey; Angela Houston; Mavuto Mukaka; Dan Komrower; Thandie Mwalukomo; Lyson Tenthani; Andreas Jahn; Michael Moore; Remco P. H. Peters; Melita A. Gordon; Dean B. Everett; Neil French; Joep J. van Oosterhout; Theresa J. Allain; Robert S. Heyderman
Introduction Blood-stream infection (BSI) is one of the principle determinants of the morbidity and mortality associated with advanced HIV infection, especially in sub-Saharan Africa. Over the last 10 years, there has been rapid roll-out of anti-retroviral therapy (ART) and cotrimoxazole prophylactic therapy (CPT) in many high HIV prevalence African countries. Methods A prospective cohort of adults with suspected BSI presenting to Queens Hospital, Malawi was recruited between 2009 and 2010 to describe causes of and outcomes from BSI. Comparison was made with a cohort pre-dating ART roll-out to investigate whether and how ART and CPT have affected BSI. Malawian census and Ministry of Health ART data were used to estimate minimum incidence of BSI in Blantyre district. Results 2,007 patients were recruited, 90% were HIV infected. Since 1997/8, culture-confirmed BSI has fallen from 16% of suspected cases to 10% (p<0.001) and case fatality rate from confirmed BSI has fallen from 40% to 14% (p<0.001). Minimum incidence of BSI was estimated at 0.03/1000 years in HIV uninfected vs. 2.16/1000 years in HIV infected adults. Compared to HIV seronegative patients, the estimated incidence rate-ratio for BSI was 80 (95% CI:46–139) in HIV-infected/untreated adults, 568 (95% CI:302–1069) during the first 3 months of ART and 30 (95% CI:16–59) after 3 months of ART. Conclusions Following ART roll-out, the incidence of BSI has fallen and clinical outcomes have improved markedly. Nonetheless, BSI incidence remains high in the first 3 months of ART despite CPT. Further interventions to reduce BSI-associated mortality in the first 3 months of ART require urgent evaluation.
Emerging Infectious Diseases | 2013
Thembi Katangwe; Janet Purcell; Naor Bar-Zeev; Brigitte Denis; Jacqui Montgomery; Maaike Alaerts; Robert S. Heyderman; David A. B. Dance; Neil Kennedy; Nicholas A. Feasey; Christopher A. Moxon
A case of human melioidosis caused by a novel sequence type of Burkholderia pseudomallei occurred in a child in Malawi, southern Africa. A literature review showed that human cases reported from the continent have been increasing.
Journal of Infection | 2015
Peter I. Waitt; Mavuto Mukaka; Patrick Goodson; Felanji Simukonda; Catriona Waitt; Nicholas A. Feasey; Theresa J. Allain; Paul Downie; Robert S. Heyderman
Summary Objective To assess mortality risk among adults presenting to an African teaching hospital with sepsis and severe sepsis in a setting of high HIV prevalence and widespread ART uptake. Methods Prospective cohort study of adults (age ≥16 years) admitted with clinical suspicion of severe infection between November 2008 and January 2009 to Queen Elizabeth Central Hospital, a 1250-bed government-funded hospital in Blantyre, Malawi. Demographic, clinical and laboratory information, including blood and cerebrospinal fluid cultures were obtained on admission. Results Data from 213 patients (181 with sepsis and 32 with severe sepsis; M:F = 2:3) were analysed. 161 (75.6%) patients were HIV-positive. Overall mortality was 22%, rising to 50% amongst patients with severe sepsis. The mortality of all sepsis patients commenced on antiretroviral therapy (ART) within 90 days was 11/28 (39.3%) compared with 7/42 (16.7%) among all sepsis patients on ART for greater than 90 days (p = 0.050). Independent associations with death were hypoxia (OR = 2.4; 95% CI, 1.1–5.1) and systolic hypotension (OR 7.0; 95% CI: 2.4–20.4). Conclusions Sepsis and severe sepsis carry high mortality among hospitalised adults in Malawi. Measures to reduce this, including early identification and targeted intervention in high-risk patients, especially HIV-positive individuals recently commenced on ART, are urgently required.
PLOS ONE | 2017
Joseph M. Lewis; Richard S. Savage; Nicholas J. Beeching; Mike Beadsworth; Nicholas A. Feasey; James A. Covington
Objectives New point of care diagnostics are urgently needed to reduce the over-prescription of antimicrobials for bacterial respiratory tract infection (RTI). We performed a pilot cross sectional study to assess the feasibility of gas-capillary column ion mobility spectrometer (GC-IMS), for the analysis of volatile organic compounds (VOC) in exhaled breath to diagnose bacterial RTI in hospital inpatients. Methods 71 patients were prospectively recruited from the Acute Medical Unit of the Royal Liverpool University Hospital between March and May 2016 and classified as confirmed or probable bacterial or viral RTI on the basis of microbiologic, biochemical and radiologic testing. Breath samples were collected at the patient’s bedside directly into the electronic nose device, which recorded a VOC spectrum for each sample. Sparse principal component analysis and sparse logistic regression were used to develop a diagnostic model to classify VOC spectra as being caused by bacterial or non-bacterial RTI. Results Summary area under the receiver operator characteristic curve was 0.73 (95% CI 0.61–0.86), summary sensitivity and specificity were 62% (95% CI 41–80%) and 80% (95% CI 64–91%) respectively (p = 0.00147). Conclusions GC-IMS analysis of exhaled VOC for the diagnosis of bacterial RTI shows promise in this pilot study and further trials are warranted to assess this technique.
Emerging Infectious Diseases | 2014
Nicholas A. Feasey; Amy K. Cain; Chisomo L. Msefula; Derek Pickard; Maaike Alaerts; Martin Aslett; Dean B. Everett; Theresa J. Allain; Gordon Dougan; Melita A. Gordon; Robert S. Heyderman; Robert A. Kingsley
Archive | 2014
Nicholas A. Feasey
Collaboration
Dive into the Nicholas A. Feasey's collaboration.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
View shared research outputs